Blood 2008-07-15
The revised World Health Organization diagnostic criteria for polycythemia vera, essential thrombocytosis, and primary myelofibrosis: an alternative proposal.   

Related Questions

Concordant low EPO level and bone marrow with megakaryocyte hyperplasia

Recurrent thromboses despite therapeutic enoxaparin. Other hypercoagulable work-up negative. 

Ropeginterferon is now a preferred therapy for Polycythemia Vera (PV) as per a recent update to the NCCN guidelines.